OYSTER PT PHARMA INC's ticker is OYST and the CUSIP is 69242L106. A total of 61 filers reported holding OYSTER PT PHARMA INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $11,612,578 | +98.7% | 1,039,622 | 0.0% | 0.39% | +235.0% |
| Q3 2022 | $5,843,000 | +29.8% | 1,039,622 | 0.0% | 0.12% | +95.0% |
| Q2 2022 | $4,502,000 | -62.8% | 1,039,622 | 0.0% | 0.06% | -45.5% |
| Q1 2022 | $12,101,000 | -36.3% | 1,039,622 | 0.0% | 0.11% | +5.8% |
| Q4 2021 | $18,983,000 | +54.1% | 1,039,622 | 0.0% | 0.10% | +70.5% |
| Q3 2021 | $12,320,000 | -31.1% | 1,039,622 | 0.0% | 0.06% | -15.3% |
| Q2 2021 | $17,871,000 | -6.0% | 1,039,622 | 0.0% | 0.07% | -25.0% |
| Q1 2021 | $19,004,000 | -2.9% | 1,039,622 | 0.0% | 0.10% | -3.0% |
| Q4 2020 | $19,566,000 | -10.8% | 1,039,622 | 0.0% | 0.10% | -20.8% |
| Q3 2020 | $21,946,000 | -26.9% | 1,039,622 | 0.0% | 0.12% | -31.7% |
| Q2 2020 | $30,024,000 | -17.5% | 1,039,622 | 0.0% | 0.18% | -21.1% |
| Q1 2020 | $36,387,000 | +43.2% | 1,039,622 | 0.0% | 0.23% | +87.1% |
| Q4 2019 | $25,408,000 | – | 1,039,622 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 2,768,586 | $32,226,000 | 14.34% |
| Paradigm Biocapital Advisors LP | 987,698 | $11,497,000 | 3.04% |
| NEA Management Company, LLC | 5,925,287 | $68,970,000 | 1.99% |
| KPCB XIV Associates, LLC | 367,987 | $4,283,000 | 1.61% |
| Telemark Asset Management, LLC | 787,026 | $9,161,000 | 0.81% |
| COWEN AND COMPANY, LLC | 509,794 | $5,934,000 | 0.57% |
| RTW INVESTMENTS, LP | 2,058,504 | $23,961,000 | 0.50% |
| ACT CAPITAL MANAGEMENT, LLC | 13,500 | $157,000 | 0.17% |
| Kohlberg Kravis Roberts & Co. L.P. | 1,039,622 | $12,101,000 | 0.11% |
| Wildcat Capital Management, LLC | 36,847 | $429,000 | 0.11% |